nivolumab and ipilimumab in mrcc
Published 5 years ago • 330 plays • Length 2:00Download video MP4
Download video MP3
Similar videos
-
4:50
ipilimumab/nivolumab in first-line mrcc
-
3:16
optimizing the use of ipilimumab/nivolumab in mrcc
-
4:46
sbrt in combination with ipilimumab/nivolumab in mrcc
-
3:07
checkmate-214: nivolumab/ipilimumab for mrcc?
-
7:03
ipilimumab/nivolumab for favorable-risk mrcc
-
0:51
dr. pal on the frontline approval of nivolumab and ipilimumab in mrcc
-
7:36
mrcc patient selection for ipilimumab/nivolumab
-
2:08
nivolumab with ipilimumab for mrcc
-
6:01
metastatic rcc: using frontline ipilimumab/nivolumab
-
1:08
dr. motzer on nivolumab/ipilimumab activity in rcc
-
1:34
fda approval of frontline nivolumab/ipilimumab combo in rcc
-
1:24
dr. mcdermott on nivolumab plus ipilimumab in rcc
-
2:25
dr. motzer on a phase ii trial of nivolumab for mrcc
-
5:31
checkmate-227: nivolumab ipilimumab in mnsclc
-
5:39
nivolumab plus ipilimumab in advanced melanoma
-
1:26
dr. andre on nivolumab plus ipilimumab in dmmr/msi-h mcrc
-
1:03
dr. long on nivolumab/ipilimumab in patients with melanoma brain metastases
-
0:59
dr. ramalingam on next steps with nivolumab/ipilimumab in nsclc
-
0:39
dr. lopes on the fda approval of nivolumab/ipilimumab in nsclc